ZNF419 and cancer: Our results demonstrated that in 11 cancers, including PRAD, LUSC, and BLCA, ZNF419 expression was associated with MSI (Figure 2C), and that ZNF419 expression was negatively related to NEO in another four cancers (Figure 2D).